Literature DB >> 21879185

[Detection of genes associated with drug resistance in Mycobacterium tuberculosis strains isolated in Chile].

Pamela Araya1, Maritza Velasco, Javier Tognarelli, Fabiola Arias, Tamara Leiva, Angélica Sccapatticio, Pablo Alviz, Jorge Fernández.   

Abstract

BACKGROUND: The incidence of acquired resistance to antituberculous drugs of Mycobacterium tuberculosis in Chile is approximately 23%. AIM: To analyze the mutations associated with drug resistance in drug resistant strains of Mycobacterium tuberculosis.
MATERIAL AND METHODS: In 28 drug resistant Mycobacterium tuberculosis strains isolated in Chile, genes leading to drug resistance were studied. DNA was amplified by polymerase chain reaction (PCR) and sequencing was carried out using the ABI PRISM big dye terminator cycle sequencing ready reaction kit.
RESULTS: In rifampicin-resistant strains, the mutations in rpoβ gene were in the codons S531W/L (56%), D516Y (16%) and D516V (16%). The predominant mutation in katG gene was in the codon S315L (73%) in isoniazid-resistant strains. The mutation S95T was found in the 71% of ciprofloxacin resistant strains. Only one ethambutol resistant strain had the M306I mutation. Three unreported mutations in katG were identified.
CONCLUSIONS: Drug resistance associated mutations of Mycobacterium tuberculosis isolated in Chile were similar to those reported abroad.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879185     DOI: /S0034-98872011000400008

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

1.  Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.

Authors:  Beatriz E Ferro; Pamela K García; Luisa Maria Nieto; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

2.  Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil.

Authors:  Rodrigo Ivan Prim; Marcos André Schörner; Simone Gonçalves Senna; Christiane Lourenço Nogueira; Anna Carolina Cançado Figueiredo; Jaquelline Germano de Oliveira; Darcita Bürger Rovaris; Maria Luiza Bazzo
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-07       Impact factor: 2.743

3.  Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study.

Authors:  Wondemagegn Mulu; Bayeh Abera; Mulat Yimer; Tadesse Hailu; Haimanot Ayele; Dereje Abate
Journal:  BMC Res Notes       Date:  2017-01-03

4.  Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.

Authors:  Flávia A D de Freitas; Vagner Bernardo; Michel K Gomgnimbou; Christophe Sola; Hélio R Siqueira; Márcia A S Pereira; Fátima C O Fandinho; Harrison M Gomes; Marcelo E I Araújo; Philip N Suffys; Elizabeth A Marques; Rodolpho M Albano
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

5.  Analysis of Mycobacterium tuberculosis Genotypic Lineage Distribution in Chile and Neighboring Countries.

Authors:  Jaime Lagos; David Couvin; Loredana Arata; Javier Tognarelli; Carolina Aguayo; Tamara Leiva; Fabiola Arias; Juan Carlos Hormazabal; Nalin Rastogi; Jorge Fernández
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.